Close investigation of the tumor immune microenvironment revealed that adding CBD-IL-12 to STEAP1-BBζ CAR T cell therapy induces tumor stromal reversion and enhances activated macrophages and cDC1 while reducing tumor-associated neutrophils. Here, MPPE1 is linked to neoplasm.